Research/art/teacher profile of a person
Name and surname:
doc. JUDr. MUDr. Patrik Palacka, PhD., MPH, MBA, LL.M.
Document type:
Research/art/teacher profile of a person
The name of the university:
Comenius University Bratislava
The seat of the university:
Šafárikovo námestie 6, 818 06 Bratislava

I. - Basic information

I.1 - Surname
Palacka
I.2 - Name
Patrik
I.3 - Degrees
Assoc. Prof., M.D., Ph.D., MPH, MBA, LL.M., J.D.
I.4 - Year of birth
1980
I.5 - Name of the workplace
2nd Department of Oncology
I.6 - Address of the workplace
Klenova 1, 833 10 Bratislava 3
I.7 - Position
Associate Professor
I.8 - E-mail address
palacka2@uniba.sk
I.9 - Hyperlink to the entry of a person in the Register of university staff
https://www.portalvs.sk/regzam/detail/5885?mode=full&do=filterForm-submit&name=Patrik&surname=Palacka&university=701000000&faculty=701010000&sort=surname&employment_state=yes&filter=Vyh%C4%BEada%C5%A5
I.10 - Name of the study field in which a person works at the university
Oncology
I.11 - ORCID iD
0000-0003-4505-0952

II. - Higher education and further qualification growth

II.1 - First degree of higher education
II.b - Year
2005
II.2 - Second degree of higher education
II.a - Name of the university or institution
Comenius University in Bratislava, Faculty of Medicine
II.b - Year
2005
II.c - Study field and programme
General Medicine
II.3 - Third degree of higher education
II.a - Name of the university or institution
Comenius University in Bratislava, Faculty of Medicine
II.b - Year
2009
II.c - Study field and programme
Internal Medicine
II.4 - Associate professor
II.a - Name of the university or institution
Comenius University in Bratislava, Faculty of Medicine
II.b - Year
2023
II.c - Study field and programme
Oncology
II.5 - Professor
II.6 - Doctor of Science (DrSc.)

III. - Current and previous employment

III.a - Occupation-position III.b - Institution III.c - Duration
Associate Professor Comenius University in Bratislava, Faculty of Medicine 2023 - until now
Research Scholar Cancer Research Institute, Biomedical Research Center of the Slovak Academy of Sciences 2023 - until now
Head - Department of Outpatient Chemotherapy National Cancer Institute, Bratislava 2017 - until now
Assistant Professor Comenius University in Bratislava, Faculty of Medicine 2011 - 2023
Medical Oncologist National Cancer Institute, Bratislava 2009 - until now
Medical Fellow National Cancer Institute, Bratislava 2005 - 2009

IV. - Development of pedagogical, professional, language, digital and other skills

IV.a - Activity description, course name, other IV.b - Name of the institution IV.c - Year
University law education (I.+II.+III. degrees) Danubius University 2013 - 2019
Law Master (LL.M.) Central European Management Institute (CEMI), Prague, Czechia 2017
Master in Business Administration (MBA) Sales Manager Academy, Vienna, Austria 2012
Master in Public Health (MPH) Slovak Medical University, Bratislava 2009 - 2012
Board Certification from Medical Oncology European Society for Medical Oncology (ESMO) 2010
Board Certification from Medical Oncology Slovak Medical University, Bratislava 2009

V. - Overview of activities within the teaching career at the university

V.1 - Overview of the profile courses taught in the current academic year according to study programmes
V.1.a - Name of the profile course V.1.b - Study programme V.1.c - Degree V.1.d - Field of study
Internal Medicine (Oncology) General Medicine I.+II. General Medicine
Oncology Oncology III. Oncology
V.2 - Overview of the responsibility for the delivery, development and quality assurance of the study programme or its part at the university in the current academic year
V.3 - Overview of the responsibility for the development and quality of the field of habilitation procedure and inaugural procedure in the current academic year
V.4 - Overview of supervised final theses
V.4.1 - Number of currently supervised theses
V.4.a - Bachelor's (first degree)
0
V.4.b - Diploma (second degree)
1
V.4.c - Dissertation (third degree)
4
V.4.2 - Number of defended theses
V.4.a - Bachelor's (first degree)
0
V.4.b - Diploma (second degree)
12
V.4.c - Dissertation (third degree)
0
V.5 - Overview of other courses taught in the current academic year according to study programmes
V.5.a - Name of the course V.5.b - Study programme V.5.c - Degree V.5.d - Field of study
Socially Important Malignancies General Medicine I.+II. General Medicine

VI. - Overview of the research/artistic/other outputs

VI.1 - Overview of the research/artistic/other outputs and the corresponding citations
VI.1.1 - Number of the research/artistic/other outputs
VI.1.a - Overall
280
VI.1.b - Over the last six years
140
VI.1.2 - Number of the research/artistic/other outputs registered in the Web of Science or Scopus databases
VI.1.a - Overall
114
VI.1.b - Over the last six years
70
VI.1.3 - Number of citations corresponding to the research/artistic/other outputs
VI.1.a - Overall
350
VI.1.b - Over the last six years
270
VI.1.4 - Number of citations registered in the Web of Science or Scopus databases
VI.1.a - Overall
340
VI.1.b - Over the last six years
265
VI.1.5 - Number of invited lectures at the international, national level
VI.1.a - Overall
1
VI.1.b - Over the last six years
1
VI.2 - The most significant research/artistic/other outputs
1

Palacka P, Holíčková A, Roška J, Makovický P, Vallová M, Biró C, Órásová E, Obertová J, Mardiak J, Ward TA, Kajo K, Chovanec M. Prognostic value of the nucleotide excision repair and translesion DNA synthesis proteins in muscle-infiltrating bladder carcinoma. BMC Cancer 2024; 24: 1103. IF: 3.4

2

Palacka P, Slopovsky J, Obertova J, Chovanec M, Rejlekova K, Sycova-Mila Z, Kollarik B, Mardiak J, Mego M. Survival prediction by baseline systemic immune-inflammation index and its changes during first-line platinum-based treatment in a Caucasian population of patients with metastatic urothelial carcinoma. Anticancer Res 2021; 41(11): 5749-5759. IF 2.435 

3

Palacka P, Gvozdjáková A, Rausová Z, Kucharská J, Slopovský J, Obertová J, Furka D, Furka S, Singh KK, Sumbalová Z. Platelet mitochondrial bioenergetics reprogramming in patients with urothelial carcinoma. Int J Mol Sci 2021; 23(1): 1-21. IF 5.6

4

Holíčková A, Roška J, Órásová E, Bruderová V, Palacka P, Jurkovičová D, Chovanec M. Response of the urothelial carcinoma cell lines to cisplatin. Int J Mol Sci 2022; 23(20): 1-21. IF 5.6

5

Palacka P, Kucharská J, Obertová J, Rejleková K, Slopovský J, Mego M, Světlovská D, Kollárik B, Mardiak J, Gvozdjáková A. Changes in CoQ10/lipids ratio, oxidative stress, and coenzyme Q10 during first-line cisplatin-based chemotherapy in patients with metastatic urothelial carcinoma. Int J Mol Sci 2022; 23(21): 1-17. IF 5.6

VI.3 - The most significant research/artistic/other outputs over the last six years
1

Palacka P, Holíčková A, Roška J, Makovický P, Vallová M, Biró C, Órásová E, Obertová J, Mardiak J, Ward TA, Kajo K, Chovanec M. Prognostic value of the nucleotide excision repair and translesion DNA synthesis proteins in muscle-infiltrating bladder carcinoma. BMC Cancer 2024; 24: 1103. IF: 3.4

2

Palacka P, Slopovsky J, Obertova J, Chovanec M, Rejlekova K, Sycova-Mila Z, Kollarik B, Mardiak J, Mego M. Survival prediction by baseline systemic immune-inflammation index and its changes during first-line platinum-based treatment in a Caucasian population of patients with metastatic urothelial carcinoma. Anticancer Res 2021; 41(11): 5749-5759. IF 2.435 

3

Palacka P, Gvozdjáková A, Rausová Z, Kucharská J, Slopovský J, Obertová J, Furka D, Furka S, Singh KK, Sumbalová Z. Platelet mitochondrial bioenergetics reprogramming in patients with urothelial carcinoma. Int J Mol Sci 2021; 23(1): 1-21. IF 5.6

4

Holíčková A, Roška J, Órásová E, Bruderová V, Palacka P, Jurkovičová D, Chovanec M. Response of the urothelial carcinoma cell lines to cisplatin. Int J Mol Sci 2022; 23(20): 1-21. IF 5,6

5

Palacka P, Kucharská J, Obertová J, Rejleková K, Slopovský J, Mego M, Světlovská D, Kollárik B, Mardiak J, Gvozdjáková A. Changes in CoQ10/lipids ratio, oxidative stress, and coenzyme Q10 during first-line cisplatin-based chemotherapy in patients with metastatic urothelial carcinoma. Int J Mol Sci 2022; 23(21): 1-17. IF 5.6

VI.4 - The most significant citations corresponding to the research/artistic/other outputs
1

Palacka P, Mego M, Obertová J, Chovanec M, Syčová-Milá Z, Mardiak J. First Slovak experience with second-line vinflunine in advanced urothelial carcinomas. Klinická onkologie 2014;27(6): 429-433.


CITATION: Passalacqua R et al.: BMC Cancer, vol. 17, no. 1, 2017, art. no. 493 -- SCI; SCOPUS

2

Palacka P, Slopovsky J, Obertova J, Chovanec M, Rejlekova K, Sycova-Mila Z, Kollarik B, Mardiak J, Mego M. Survival prediction by baseline systemic immune-inflammation index and its changes during first-line platinum-based treatment in a Caucasian population of patients with metastatic urothelial carcinoma. Anticancer Res 2021; 41(11): 5749-5759.


CITATION: Li J et al. Frontiers in Immunology, vol. 13, 2022, art. no. 865643 -- SCI; SCOPUS

3

Slopovsky J, Kucharska J, Obertova J, Mego M, Kalavska K, Cingelova S, Svetlovska D, Gvozdjakova A, Furka S, Palacka P. Plasma thiobarbituric acid reactive substances predicts survival in chemotherapy naïve patients with metastatic urothelial carcinoma. Transl Oncol 2021; 14(1): 1-6.


CITATION: Liu JY et al. European Journal of Medical Research, vol. 28, no. 1, 2023, art. no. 469 -- SCI ; SCOPUS

4

Palacka P, Gvozdjáková A, Rausová Z, Kucharská J, Slopovský J, Obertová J, Furka D, Furka S, Singh KK, Sumbalová Z. Platelet mitochondrial bioenergetics reprogramming in patients with urothelial carcinoma. Int J Mol Sci 2021; 23(1): 1-21.


CITATION: Chen LL et al. Frontiers in Oncology, vol. 13, 2023, art.no. 1121401 -- SCI; SCOPUS

5

Palacka P, Gvozdjáková A, Rausová Z, Kucharská J, Slopovský J, Obertová J, Furka D, Furka S, Singh KK, Sumbalová Z. Platelet mitochondrial bioenergetics reprogramming in patients with urothelial carcinoma. Int J Mol Sci 2021; 23(1): 1-21.


CITATION: Teng Y: International Journal of Molecular Sciences, vol. 24, no. 9, 2023, art. no. 7693 -- SCI; SCOPUS

VI.5 - Participation in conducting (leading) the most important research projects or art projects over the last six years
1

Therapeutic potential of stress-reducing intervention in complex cancer care.

Position: Sub-Investigator (SI).

APVV-22-0231

2

The role of DNA damage and repair in the response of urogenital tract tumours to cisplatin-based chemotherapy.

Position: SI.

VEGA 2/0075/23

3

Identification and validation of biomarkers and underlying molecular pathways of late toxicity of curative treatment in testicular germ cell tumours.

Position: SI.

APVV-19-0411

4

Identification of biomarkers associated with late toxicity of chemotherapy in testicular germ cell tumours.

Position: SI. 

APVV-15-0086

VII. - Overview of organizational experience related to higher education and research/artistic/other activities

VII.a - Activity, position VII.b - Name of the institution, board VII.c - Duration
Rewieving of specialization theses Comenius University in Bratislava, Faculty of Medicine 2011 - until now
Supervising and rewieving of diploma theses Comenius University in Bratislava, Faculty of Medicine 2011 - until now

VIII. - Overview of international mobilities and visits oriented on education and research/artistic/other activities in the given field of study

VIII.a - Name of the institution VIII.b - Address of the institution VIII.c - Duration (indicate the duration of stay) VIII.d - Mobility scheme, employment contract, other (describe)
Département de Médicine Oncologique, Institut Gustave Roussy, Cancer Campus Villejuif, Grand Paris, France 2022 Observership

IX. - Other relevant facts

IX.a - If relevant, other activities related to higher education or research/artistic/other activities are mentioned

Membership: American Society of Clinical Oncology (ASCO), European Society for Medical Oncology (ESMO), Slovak Medical Society,

Slovak Oncology Society (SOS), Geriatric Section of the SOS


Membership: Slovak Medical Association


2010 - until now Member of the Onkológia (Bratislava) Editorial Board


2008 Biotherapy Scientific Award for important contribution in experimental field, Prague, Czechia

2002 Student Scientific Conference Award, Faculty of Chemical and Food Technology, Slovak University of Technology, Bratislava

2002 Student Scientific Conference Award, Faculty of Medicine, Comenius University, Bratislava

Date of last update
2025-02-28